DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,847 | +16.8% | 79,272 | +2.2% | 0.01% | +25.0% |
| Q2 2023 | $1,002,243 | +25.4% | 77,573 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $799,319 | -9.2% | 81,480 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $880,024 | +88.0% | 82,709 | +84.5% | 0.00% | +100.0% |
| Q3 2022 | $468,000 | +123.9% | 44,831 | +170.0% | 0.00% | +100.0% |
| Q2 2022 | $209,000 | +2.5% | 16,607 | -11.7% | 0.00% | 0.0% |
| Q1 2022 | $204,000 | -81.7% | 18,818 | -67.5% | 0.00% | -80.0% |
| Q3 2021 | $1,112,000 | +23.6% | 57,885 | -36.6% | 0.01% | +25.0% |
| Q2 2021 | $900,000 | -33.1% | 91,345 | -33.2% | 0.00% | -33.3% |
| Q1 2021 | $1,345,000 | +773.4% | 136,834 | +296.5% | 0.01% | +500.0% |
| Q4 2020 | $154,000 | -7.8% | 34,512 | +215.8% | 0.00% | 0.0% |
| Q2 2018 | $167,000 | -47.3% | 10,929 | -31.5% | 0.00% | -50.0% |
| Q1 2018 | $317,000 | – | 15,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |